Subsequent primary malignancies and acute myelogenous leukemia transformation among myelodysplastic syndrome patients treated with or without lenalidomide.
about
Subsequent primary malignancies and acute myelogenous leukemia transformation among myelodysplastic syndrome patients treated with or without lenalidomide.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 April 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Subsequent primary malignancie ...... with or without lenalidomide.
@en
Subsequent primary malignancie ...... with or without lenalidomide.
@nl
type
label
Subsequent primary malignancie ...... with or without lenalidomide.
@en
Subsequent primary malignancie ...... with or without lenalidomide.
@nl
prefLabel
Subsequent primary malignancie ...... with or without lenalidomide.
@en
Subsequent primary malignancie ...... with or without lenalidomide.
@nl
P2093
P2860
P356
P1433
P1476
Subsequent primary malignancie ...... d with or without lenalidomide
@en
P2093
Dana E Rollison
Eric Padron
Jeffrey Lancet
Ji-Hyun Lee
Kate Fisher
Kenneth H Shain
Laurie Kenvin
Martha Olesnyckyj
Najla H Al Ali
P2860
P304
P356
10.1002/CAM4.721
P407
P50
P577
2016-04-20T00:00:00Z